anmelden
FTSE All-Share
5.634,42
PKT
-0,63
PKT
-0,01
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu FTSE All-Share-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 07.11.23 | AstraZeneca Hold | Deutsche Bank AG | |
| 06.11.23 | BP Buy | Goldman Sachs Group Inc. | |
| 03.11.23 | Shell (ex Royal Dutch Shell) Conviction Buy List | Goldman Sachs Group Inc. | |
| 03.11.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 03.11.23 | Shell (ex Royal Dutch Shell) Overweight | JP Morgan Chase & Co. | |
| 02.11.23 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 02.11.23 | Diageo Overweight | JP Morgan Chase & Co. | |
| 02.11.23 | Unilever Underweight | JP Morgan Chase & Co. | |
| 02.11.23 | BAT Neutral | JP Morgan Chase & Co. | |
| 02.11.23 | Shell (ex Royal Dutch Shell) Conviction Buy List | Goldman Sachs Group Inc. | |
| 02.11.23 | GSK Buy | Deutsche Bank AG | |
| 02.11.23 | Shell (ex Royal Dutch Shell) Buy | Jefferies & Company Inc. | |
| 02.11.23 | Shell (ex Royal Dutch Shell) Buy | UBS AG | |
| 02.11.23 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 02.11.23 | GSK Underweight | JP Morgan Chase & Co. | |
| 02.11.23 | BP Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 01.11.23 | GSK Sell | UBS AG | |
| 01.11.23 | HSBC Neutral | UBS AG | |
| 01.11.23 | GSK Hold | Jefferies & Company Inc. | |
| 01.11.23 | BP Buy | Goldman Sachs Group Inc. | |
| 01.11.23 | BP Underweight | JP Morgan Chase & Co. | |
| 31.10.23 | HSBC Outperform | RBC Capital Markets | |
| 31.10.23 | HSBC Overweight | Barclays Capital | |
| 31.10.23 | BP Neutral | JP Morgan Chase & Co. | |
| 31.10.23 | Vodafone Group Neutral | JP Morgan Chase & Co. | |
| 31.10.23 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 31.10.23 | Vodafone Group Buy | UBS AG | |
| 31.10.23 | BP Hold | Jefferies & Company Inc. | |
| 31.10.23 | BP Buy | Goldman Sachs Group Inc. | |
| 31.10.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 31.10.23 | BP Outperform | RBC Capital Markets | |
| 31.10.23 | BP Buy | UBS AG | |
| 31.10.23 | Vodafone Group Buy | Goldman Sachs Group Inc. | |
| 31.10.23 | HSBC Buy | Deutsche Bank AG | |
| 31.10.23 | HSBC Buy | Goldman Sachs Group Inc. | |
| 30.10.23 | HSBC Neutral | JP Morgan Chase & Co. | |
| 30.10.23 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 30.10.23 | HSBC Outperform | RBC Capital Markets | |
| 30.10.23 | HSBC Neutral | UBS AG | |
| 30.10.23 | HSBC Buy | Jefferies & Company Inc. |